DNA binding and cytotoxicity studies of magnetic nanofluid containing antiviral drug oseltamivir.
In this work, the possibility of preparing a nanoparticle with improved treatment properties was investigated. In this regard, synthesis, characterization, in vitro cytotoxicity and DNA binding of Fe3O4@oleate/oseltamivir magnetic nanoparticles (MNPs) were investigated. Fe3O4 nanoparticles were synthesized via chemical co-precipitation and coated by oleate bilayers. Then, Fe3O4@OA MNPs were functionalized with an antiviral drug (oseltamivir), for better biological applications. The MNPs were subsequently characterized by zeta sizer and Zeta potential measurements, Fourier transform infrared (FT-IR) spectroscopy, vibrating sample magnetometer (VSM) and transmission electron microscopy (TEM) analyses. The TEM image demonstrated that average sizes of Fe3O4@OA/oseltamivir MNPs were about 8 nm. The in vitro cytotoxicity of Fe3O4@OA/oseltamivir MNPs was studied against cancer cell lines (MCF-7 and MDA-MB-231) and compared with oseltamivir drug. The results illustrated that Fe3O4@OA/oseltamivir magnetic nanoparticles have better antiproliferative effects on the mentioned cell lines as compared with oseltamivir. Also, in vitro DNA binding studies were done by UV-Vis, circular dichroism, and Fluorescence spectroscopy. The results indicated that Fe3O4@OA/oseltamivir MNPs bound to DNA via groove binding. Moreover, this magnetic nanofluid has potential for magnetic hyperthermia therapy due to magnetic core of its nanoparticles. Communicated by Ramaswamy H. Sarma.